| Crystal structure of human ADP-ribose pyrophosphatase NUDT5 | | homo-2-mer | 14-219 | 100 | |
|
| Crystal Structure of Human ADP-ribose Pyrophosphatase NUDT5 In complex with magnesium and AMPcpr | | homo-2-mer | 13-209 | 100 | 6×MG; 2×ADV; |
|
| Human NUDT5 in complex with MRK-952 | | homo-2-mer | 12-208 | 100 | 2×F2V; 4×MG; |
|
| Crystal structure of human NUDT5 complexed with 8-oxo-dADP and manganese | | homo-2-mer | 13-208 | 100 | 5×MN; 2×8DD; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×K31; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×K0J; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K34; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×EDO; 2×K1P; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×K3M; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K2V; 2×EDO; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-3764 | | homo-2-mer | 14-208 | 100 | 4×MG; 3×EDO; 2×PWP; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K1S; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×K3Y; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×JMM; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×K3V; 2×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K2M; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K0V; 3×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×K1Y; 2×EDO; |
|
| Ground-state model of NUDT5 and corresponding apo datasets for PanDDA analysis | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×K2J; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×K0M; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×K24; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×K1V; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×K3D; 2×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×EDO; 1×K0S; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K3J; 3×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K0A; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K1D; 3×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 3×EDO; 1×GQJ; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×EDO; 1×CL; 1×JH4; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 4×EDO; 2×JJM; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K07; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×EDO; 2×K3P; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 1R-0641 | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×PWG; 3×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×EDO; 1×K1A; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 3×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×K3S; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×K3A; 2×EDO; 1×CL; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with Z44592329 | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K0G; 1×EDO; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with GB-0804 | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 3×EDO; 2×PW7; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with AE-0227 | | homo-2-mer | 14-208 | 100 | 4×MG; 2×PWJ; 4×EDO; 1×CL; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×EDO; 1×K2P; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×K1G; 1×CL; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 3×EDO; 1×K0P; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×EDO; 1×ELQ; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K2G; 3×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K1J; 4×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K2S; 3×EDO; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-2639 | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×PWA; 3×EDO; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-1169 | | homo-2-mer | 14-208 | 100 | 4×MG; 2×PWM; 3×EDO; 1×CL; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with SS-4432 | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×PWD; 2×EDO; |
|
| PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 8J-537S | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×PWS; 5×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K0D; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 2×K04; 2×EDO; 1×CL; |
|
| Crystal structure of human NUDT5 | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 2×K41; 2×EDO; |
|
| Crystal structure of human ADP-ribose pyrophosphatase NUDT5 in complex with magnesium and ADP-ribose | | homo-2-mer | 14-208 | 100 | 2×MG; 2×APR; |
|
| Crystal Structure of Human ADP-ribose Pyrophosphatase NUDT5 In complex with Ibrutinib | | homo-2-mer | 14-208 | 100.0 | 4×MG; 2×A1H14; 2×EDO; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | homo-2-mer | 14-208 | 100 | 4×MG; 1×CL; 1×K0Y; 2×EDO; |
|
| Crystal structure of human NUDT5 complexed with 8-oxo-dGDP and manganese | | homo-2-mer | 14-208 | 100 | 2×8GD; 2×MN; |
|
| Potent inhibitors of NUDT5 silence hormone signaling in breast cancer | | homo-2-mer | 14-208 | 100 | 3×958; |
|
| Human NUDT5 with ibrutinib derivative | | homo-2-mer | 14-208 | 100 | 2×W0O; |
|
| Crystal structure of human NUDT5 complexed with 8-oxo-dGMP | | homo-2-mer | 14-208 | 100 | 2×8OG; |
|
| Crystal structure of human ADP-ribose pyrophosphatase NUDT5 in complex with magnesium and AMP | | homo-2-mer | 14-208 | 100 | 6×MG; 2×AMP; |
|
| Potent inhibitors of NUDT5 silence hormone signaling in breast cancer | | homo-2-mer | 14-208 | 100.0 | 2×9CH; |
|